# IntelliRay

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/intelliray

- Industry: Healthcare Specialists
- Headquarters: Shenyang, China
- Website: www.intelliray.com.cn
- Total disclosed funding: $67M
- Latest round: Series C (Jun 17, 2024)
- Investors on record: 6

## About

Founded in 2018 and based in Shenyang, China, IntelliRay is a medical company that focuses on the research and development of oncology radiotherapy technologies, products, and solutions. The company is the wholly owned subsidiary of Neusoft Medical. IntelliRay was recognized as the National High-tech Enterprise. The company has more than 40 patents. It cooperated with In Sun Yat-sen University Cancer Center, China Electronics Technology Group Corporation, Southern Medical University, etc. The company has 37 service teams and 21 spare parts centers at home and abroad. Shaojie Wu, the chairman of the company, used to work in Shanghai Neusoft Medical Equipment and other companies. In June 2024, IntelliRay raised a series C funding for over CNY 100 million.

IntelliRay mainly provides oncology radiotherapy solutions based on artificial intelligence, cloud computing, and other technologies. Its products include NeuRT Aurora Smart Radiotherapy Platforms, NeuOIS Polaris Aurora Oncology Information Systems, and NeuOIS Cloud Aurora Remote Radiotherapy Platforms. The NeuRT Aurora Smart Radiotherapy Platforms are equipped with fiber-optic distributed real-time control systems (RTCS) and iCBCT diagnostic-grade image guidance systems, which adopt Spiral Volume Modulation Therapy (SVMAT) technology. Products and solutions mainly serve oncology patients.

The company generates revenue by providing oncology radiotherapy products and solutions.

The company will use the series C funding to develop radiotherapy equipment and information technology systems, expand markets, and construct new industrial bases, etc.

## Funding rounds

- Series C, Jun 17, 2024, $14M — Neusoft Venture Capital, Yueli Capital
- Series B, Nov 1, 2021, $39M — Neusoft Venture Capital, 6 Dimensions Capital, Lenovo Capital and Incubator Group, In Capital
- Series A, Jun 9, 2020, $14M — Ivy Capital, 6 Dimensions Capital

## Investors

- Ivy Capital (https://capitalatlas.ai/funds/ivy-capital) — Series A
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series A, Series B
- Neusoft Venture Capital (https://capitalatlas.ai/funds/neusoft-venture-capital) — Series B, Series C
- Lenovo Capital and Incubator Group (https://capitalatlas.ai/funds/lenovo-capital-and-incubator-group) — Series B
- In Capital — Series B
- Yueli Capital (https://capitalatlas.ai/funds/yueli-capital) — Series C